peptidemimetic

Peptidemimetics, or peptidomimetics, are compounds designed to imitate the functional properties of natural peptides while altering the chemical structure to resist enzymatic degradation and improve pharmacokinetic properties. They aim to preserve the spatial arrangement of key pharmacophores and hydrogen-bond donors and acceptors that drive receptor binding and biological activity, but with non-peptide backbones or modified peptide bonds.

Design strategies include replacing the peptide bond with isosteres such as reduced amide, reversed peptide (retro-inverso) linkages, or non-amide linkages; backbone modifications such as incorporation of beta- or gamma-amino acids; side-chain mimics like N-substituted glycines (peptoids); and conformational constraints through cyclization or macrocyclization, hydrocarbon stapling, or rigid scaffolds that present functional groups in a biomimetic orientation.

Major classes and examples include beta-peptides, peptoids, and other non-peptide scaffolds that mimic peptide secondary structures; cyclized peptidomimetics; and heterocyclic mimetics. Peptidemimetics are designed to retain receptor affinity while improving stability to proteolysis and oral bioavailability compared with native peptides.

Applications include drug discovery and chemical biology, where they serve as protease inhibitors, receptor ligands, enzyme inhibitors, and modulators of protein–protein interactions. Advantages include enhanced metabolic stability, longer half-life, and better tissue penetration; challenges involve synthetic complexity, potential off-target effects, immunogenicity, and the difficulty of predicting three-dimensional conformation and activity.

---